Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Seigo Korematsu is active.

Publication


Featured researches published by Seigo Korematsu.


Clinical & Experimental Allergy | 2011

Elevated umbilical cord serum TARC/CCL17 levels predict the development of atopic dermatitis in infancy

Hiroaki Miyahara; Naho Okazaki; Tomokazu Nagakura; Seigo Korematsu; Tatsuro Izumi

Cite this as: H. Miyahara, N. Okazaki,T. Nagakura, S. Korematsu and T. Izumi,Clinical & Experimental Allergy, 2011 (41) 186–191.


PLOS ONE | 2011

Sex- and age-related differences in morbidity rates of 2009 pandemic influenza A H1N1 virus of swine origin in Japan.

Nobuoki Eshima; Osamu Tokumaru; Shohei Hara; Kira Bacal; Seigo Korematsu; Minoru Tabata; Shigeru Karukaya; Yoshinori Yasui; Nobuhiko Okabe; Toyojiro Matsuishi

Background The objective of the present study was to determine whether the morbidity rates of the 2009 pandemic influenza A H1N1 virus (pdmH1N1) varied by age and/or sex. Methods and Findings Retrospective analysis of 2,024,367 cases of pdmH1N1 was performed using the national surveillance data from influenza sentinel points in Japan. The male-to-female morbidity ratios (M/F ratios) in nineteen age groups were estimated as the primary outcome. The M/F ratios for pdmH1N1 influenza were: >1 in age groups <20 years and ≥80 years (p<0.001); <1 in age groups 20–79 years (p<0.001). This data suggests that males <20 years of age may be more likely to suffer from pdmH1N1 influenza than females in the same age categories. When the infection pattern for pdmH1N1was compared with that of seasonal influenza outbreaks between 2000 and 2008, the M/F ratio for pdmH1N1 influenza was higher in ages 3–29 years and lower in ages 40–79 years. Because the present study was based on the national surveillance, it was impossible to estimate the morbidity rate for the Japanese population. It is also likely that the data did not capture asymptomatic or mild infections. Conclusions Although exposure to the pdmH1N1 virus is assumed to be similar in both boys and girls, M/F ratios were >1 in those younger than 20 years. The subsequent reversal of the M/F ratio in the adult generation could be due to several possibilities, including: greater immunity among adult males, more asymptomatic infections among males, less reporting of illness by males, or differences in exposure to the virus and probability of visiting a clinic. These results suggest that the infection and virulence patterns of pdmH1N1 are more complex than previously considered.


PLOS ONE | 2012

Age-Specific Sex-Related Differences in Infections: A Statistical Analysis of National Surveillance Data in Japan

Nobuoki Eshima; Osamu Tokumaru; Shohei Hara; Kira Bacal; Seigo Korematsu; Shigeru Karukaya; Kiyo Uruma; Nobuhiko Okabe; Toyojiro Matsuishi

Background To prevent and control infectious diseases, it is important to understand how sex and age influence morbidity rates, but consistent clear descriptions of differences in the reported incidence of infectious diseases in terms of sex and age are sparse. Methods and Findings Data from the Japanese surveillance system for infectious diseases from 2000 to 2009 were used in the analysis of seven viral and four bacterial infectious diseases with relatively large impact on the Japanese community. The male-to-female morbidity (MFM) ratios in different age groups were estimated to compare incidence rates of symptomatic reported infection between the sexes at different ages. MFM ratios were >1 for five viral infections out of seven in childhood, i.e. male children were more frequently reported as infected than females with pharyngoconjunctival fever, herpangina, hand-foot-and-mouth disease, mumps, and varicella. More males were also reported to be infected with erythema infectiosum and exanthema subitum, but only in children 1 year of age. By contrast, in adulthood the MFM ratios decreased to <1 for all of the viral infections above except varicella, i.e. adult women were more frequently reported to be infected than men. Sex- and age-related differences in reported morbidity were also documented for bacterial infections. Reported morbidity for enterohemorrhagic Escherichia coli infection was higher in adult females and females were reportedly more infected with mycoplasma pneumonia than males in all age groups up to 70 years. Conclusions Sex-related differences in reported morbidity for viral and bacterial infections were documented among different age groups. Changes in MFM ratios with age may reflect differences between the sexes in underlying development processes, including those affecting the immune, endocrine, and reproductive systems, or differences in reporting rates.


Vaccine | 2009

A relapse of systemic type juvenile idiopathic arthritis after a rubella vaccination in a patient during a long-term remission period

Seigo Korematsu; Hiroaki Miyahara; Tatsuya Kawano; Hiroshi Yamada; Keisuke Sato; Tomoki Maeda; So-ichi Suenobu; Tatsuro Izumi

An 11-year-old female patient, whose systemic type juvenile idiopathic arthritis (JIA) had maintained in remission for the previous 4 years while taking only a small amounts of ibuprofen, showed an abrupt 2nd relapse with congestive heart failure five days after receiving a live-attenuated rubella vaccine, which was a primary immunization. Her serum levels of anti-rubella IgM and IgG antibodies increased, and her laboratory findings such as a leukocytosis, elevated serum levels of CRP, IL-6 and other inflammatory cytokine profiles were similar to the findings observed during her previous JIA active stage. After being administration of co-therapy with steroid pulse, ibuprofen, methotrexate and phosphodiesterase inhibitor gradually improved her clinical symptoms such as spiky fever, heart failure and arthralgia. Her intermittent fever and increased serum levels of CRP and IL-6, however, have been sustained for more than 2 years, and this prolonged active clinical course therefore differed from her previous JIA active stage.This abrupt relapse only five days after vaccination was suggested not to be directly related with rubella infection, but instead to be related with the molecular mimicry between rubella and JIA.


Pediatric Dermatology | 2011

Neonatal Onset Diffuse Cutaneous Mastocytosis: A Case Report and Review of the Literature

Hiroshi Koga; Takayuki Kokubo; Mutsumi Akaishi; Koichi Iida M.D.; Seigo Korematsu

Abstract:  Diffuse cutaneous mastocytosis is a rare variant of mast cell disease with widespread erythroderma, which is normally clinically apparent in early infancy. We report the case of a neonate who presented with diffuse erythrodermic rash and bullous lesions. Biopsy specimens showed a dense dermal infiltrate of mast cells. Serum histamine and tryptase levels were elevated. No somatic mutation of the c‐kit gene was found. Blistering ceased at 5 months of age, but atopic dermatitis appeared at 6 months and allergic workup revealed a high level of food‐specific IgE. Herein, we describe the case and provide the first review of the literature on neonatal onset diffuse cutaneous mastocytosis to clarify the prognosis of this condition.


Pediatrics International | 2008

Theophylline-associated seizures and their clinical characterizations

Seigo Korematsu; Hiroaki Miyahara; Tomokazu Nagakura; So-ichi Suenobu; Tatsuro Izumi

Background: To elucidate the basic mechanism of theophylline‐associated seizures (TAS), the clinical symptoms, electroencephalogram (EEG) and neuroradiological imaging of eight pediatric patients were all retrospectively evaluated.


Pediatric Allergy and Immunology | 2010

The indication and effectiveness of low-dose erythromycin therapy in pediatric patients with bronchial asthma*

Seigo Korematsu; Kyoko Yamamoto; Tomokazu Nagakura; Hiroaki Miyahara; Naho Okazaki; Tomoki Maeda; So-ichi Suenobu; Tatsuro Izumi

Korematsu S, Yamamoto K, Nagakura T, Miyahara H, Okazaki N, Akiyoshi K, Maeda T, Suenobu S‐i, Izumi T. The indication and effectiveness of low‐dose erythromycin therapy in pediatric patients with bronchial asthma.
Pediatr Allergy Immunol 2010: 21: 489–492.
© 2010 John Wiley & Sons A/S


Brain & Development | 2009

The subclassification of schizencephaly and its clinical characterization

Tomoki Maeda; Mutsumi Akaishi; Miki Shimizu; Kazuhito Sekiguchi; Aki Anan; Tomoyuki Takano; Kazuhide Imai; So-ichi Suenobu; Seigo Korematsu; Tatsuro Izumi

We subclassified schizencephaly based on the association with optic nerve hypoplasia (ONH) and the absence of the septum pellucidum (ASP), and then characterized their clinical presentation and prognosis. The subjects of our study consisted of 10 cases with a mean age at the final evaluation of 10 years 3 months (range, 7 months to 25 years). The subclassification of schizencephaly consisted of the septo-optic dysplasia (SOD) group (n=3), with ONH and ASP; the optic hypoplasia (OHP) group (n=2), with ONH and without ASP, and; the classical group (n=5), without ONH. The subjects with an open-lip cleft in the SOD and the classical group showed hydrocephalus, but those in the OHP group did not. The SOD and the OHP group displayed severe psychomotor retardation regardless of the cleft morphology, but in the classical group, the subjects with an open-lip cleft or with diffuse cortical dysplasia were severely retarded. The SOD and the OHP group displayed intractable epilepsy. In contrast, all subjects in the classical group showed good control of epilepsy. The results of our investigation show that the subclassification of schizencephaly based on the association with ONH and ASP is useful. The SOD group means early fetal brain injury which results in extended cortical dysplasia while the OHP group means severe destructive brain injury which results in cerebro-cerebellar disruption.


Pediatric Infectious Disease Journal | 2007

The characterization of cerebrospinal fluid and serum cytokines in patients with Kawasaki disease.

Seigo Korematsu; Shin-ichi Uchiyama; Hiroaki Miyahara; Tomokazu Nagakura; Naho Okazaki; Tatsuya Kawano; Masanobu Kojo; Tatsuro Izumi

Background: The central nervous system (CNS) inflammation of Kawasaki disease (KD) has not been sufficiently evaluated in spite of the complications of irritability and CSF pleocytosis. Patients and Methods: Cerebrospinal fluid (CSF) and serum inflammatory cytokine values were simultaneously examined in 10 patients (2.6 ± 2.1 year of age) during the acute phase. They were all irritable and demonstrated mild consciousness disturbance. Results: The CSF IL6 was elevated (>3.0 pg/mL) in 6 patients, and 4 of them showed higher CSF than serum values. The CSF sTNFR1 was elevated (>0.5 μg/mL) in 6 patients, and 1 showed higher CSF than serum values. These CSF cytokine (IL6; 81.4 ± 192.8 pg/mL, sTNFR1; 1.1 ± 0.8 μg/mL) and CSF/serum ratio (IL6; 2.8 ± 5.2, sTNFR1 0.4 ± 0.4) in patients with KD were the same as those of patients with acute encephalitis/acute encephalopathy. Conclusions: The differences in the inflammatory cytokine value between CSF and serum suggest that the degree of systemic vasculitis is different between CSF and the circulating blood, and some patients with KD showed a higher degree of CSF inflammation.


Vaccine | 2011

Detection of platelet-binding anti-measles and anti-rubella virus IgG antibodies in infants with vaccine-induced thrombocytopenic purpura.

Naho Okazaki; Masahiro Takeguchi; Kohji Sonoda; Yohsuke Handa; Tatsuo Kakiuchi; Hiroaki Miyahara; Seigo Korematsu; So-ichi Suenobu; Tatsuro Izumi

A 15-month-old infant presented with thrombocytopenic purpura after sequential administration of measles-rubella combined vaccine, varicella vaccine and mumps vaccine every 4 weeks. Her thrombocytopenia persisted for more than 12 months. Both anti-measles and anti-rubella virus IgG antibodies were detected in the patients-isolated platelets on day 154 of illness, which were not detected when there was a reduction of the serum IgG antibody titers on days 298 and 373 of illness, respectively.We also detected the isolated platelet-binding anti-measles and anti-rubella virus IgG antibodies in two other pediatric patients. This is the first report demonstrating direct evidence of vaccine-induced thrombocytopenic purpura.

Collaboration


Dive into the Seigo Korematsu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge